SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10195reuters.com Another bump in the road.... can't Elan's management get anArthur Radley19/3/2009
10194That comparison between US sales of Copaxone and Tysabri is amazing. IMO, it spHarold Engstrom18/11/2009
10193Excerpt: In seeking declaratory relief, Elan has requested that the Court conducQualified Opinion-8/6/2009
10192August 06, 2009 10:15 AM Eastern Daylight Time Elan Files Declaratory Suit AQualified Opinion-8/6/2009
10191finance.yahoo.com Finally some goods news about Elan technology.....stock is geArthur Radley-7/31/2009
10190Copaxone vs Tysabri in the US Market <pre><b> Tysabri CopaxDewDiligence_on_SI-7/28/2009
10189Doctors ard patient advocacy groups will have the insider information on TysabriQualified Opinion-7/24/2009
10188Who was trading the insider information on PML ? Whose idea included a weekly PMQualified Opinion-7/24/2009
10187For the record, last weekly PML Friday, link: phx.corporate-ir.netQualified Opinion-7/24/2009
10186Merck KGaA has submitted a European filing for cladribine Report from May: NeQualified Opinion-7/23/2009
10185BIIB closing strong -tom pope-7/21/2009
10184So whoever buys BIIB has to deal with JNJ, unless the buyer just happens to be..fred hayes-7/21/2009
10183DUBLIN, July 21 (Reuters) - Elan (ELN.I) said on Tuesday it gave U.S. healthcareArthur Radley-7/21/2009
10182cnbc.comArthur Radley-7/16/2009
10181"During the second quarter we drove a clear acceleration of Tysabri patienttom pope27/16/2009
10180Alzheimer’s Doctors Rethink Disease After Mice Study (Update1) By Michelle FayQualified Opinion-7/15/2009
10179In the ongoing phase II trial, they test 2 lower doses of 250mg and 1,000mg in aidos-7/15/2009
10178Thanks for the link, I had seen that. I wanted to park that abstract to remind Biotech Jim-7/15/2009
10177They presented 2 posters at ICAD, see the 2nd one on phase I pk data here (showeidos-7/15/2009
10176Promising Alzheimer's drug boosts toxic protein Wed Jul 15, 2009 2:30am EDT Qualified Opinion-7/15/2009
10175Parking this abstract on scyllo-inositol (ELND-005/AZD-103) J Mol Med. 2007 JunBiotech Jim-7/14/2009
10174yes, if bap gains approval and is best drug available, elan will certainly go coewolf-7/3/2009
10173Ever a chance in hell of reaching $30 again?steve kammerer-7/3/2009
10172<i>Good deal for J&J.</i> I concur emphatically: siliconinvestoDewDiligence_on_SI17/3/2009
10171Staff working on the Wyeth partnership programs have been doing it for years andfred hayes-7/2/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News